Net earnings (USD, thousands)

Depreciation and amortization (USD, thousands)

Provision for excess and obsolete inventory (USD, thousands)

Amortization of deferred compensation related to stock-based awards (USD, thousands)

Deferred income tax expense (benefit) (USD, thousands)

Net cash provided by operating activities (USD, thousands)

Acquisition of business, net of cash acquired (USD, thousands)

Purchase of property and equipment (USD, thousands)

Net cash used in investing activities (USD, thousands)

Repayments of long-term borrowings (USD, thousands)

Proceeds from stock options exercised (USD, thousands)

Proceeds from shares sold under Employee Stock Purchase Plan (USD, thousands)

Settlement of employee tax liabilities in connection with treasury stock transaction (USD, thousands)

Net cash (used in) provided by financing activities (USD, thousands)

Effects of exchange rates on cash (USD, thousands)

Net cash (used in) provided by all activities (USD, thousands)

Cash payments for: Domestic and foreign income taxes (USD, thousands)

Issuance of unvested shares of restricted stock (USD, thousands)

Forfeiture of unvested shares of restricted stock (USD, thousands)

Cash, cash equivalents and restricted cash at beginning of period (USD, thousands)

b346962ea1e4a1efc6ed21109ab53059a3ec9105cb6c9e69332fcc5cbc60660b

The significant drop in **Cash and cash equivalents** in Q1 2024 was primarily caused by the **acquisition of Alfamation**, which consumed approximately **$19 million** in cash. This major outflow was further compounded by a net cash outflow from investing activities of **$(19,244) thousand**, as well as additional cash used for financing activities of **$(874) thousand**, partly offset by operating cash inflows of **$2,075 thousand**.  **[0001437749-24-014830_ex_667815.htm:2]** **[0001437749-24-015682_intt20240331_10q.htm:6]** 

What caused the significant drop in Cash and cash equivalents in Q1 2024?

The sharp increase in Total Assets in Q1 2024 was primarily driven by the acquisition of **Alfamation S.p.A.** on March 12, 2024, which involved a **$21.76 million** purchase (comprising **$19 million** in cash and shares valued at **$2.086 million**) and led to significant increases in **Goodwill** (from **$21,728 thousand** to **$33,278 thousand**) and **Intangible Assets, net** (from **$16,596 thousand** to **$28,819 thousand**).  **[0001437749-24-015682_intt20240331_10q.htm:7]**  Additionally, increases in **Inventories** (from **$20,089 thousand** to **$31,331 thousand**), **Trade Accounts Receivable, net** (from **$18,175 thousand** to **$22,859 thousand**), and **Right-of-Use Assets, net** (from **$4,987 thousand** to **$6,270 thousand**) further contributed to the asset growth, despite a reduction in **Cash and Cash Equivalents** due to the cash payment.  **[0001437749-24-014830_ex_667815.htm:9]** **[0001437749-24-015682_intt20240331_10q.htm:3]** 

What drove the sharp increase in Total assets in Q1 2024?

The **current portion of the debt nearly doubled** in Q1 2024 because the company assumed additional debt in connection with the acquisition of Alfamation, which included both fixed and variable rate bank-issued term loans as well as short-term variable rate financing backed by Alfamation's accounts receivable.  **[0001437749-24-015682_intt20240331_10q.htm:3]** **[0001437749-24-014830_ex_667815.htm:9]** **[0001437749-24-015682_intt20240331_10q.htm:25]** 

Why did the current debt portion nearly double in Q1 2024?

The **abrupt rise** in total liabilities in Q1 2024 was primarily driven by the **acquisition of Alfamation S.p.A.**, which added **$9,418 thousand** in assumed debt along with additional acquisition-related liabilities (such as contingent consideration and deferred revenue adjustments).  **[0001437749-24-015682_intt20240331_10q.htm:7]**  This increase was further compounded by higher **current liabilities**—including a rise in accounts payable, accrued wages and benefits, and customer deposits—as well as an increase in **long-term debt** and the recording of a new **deferred tax liability of $1,126 thousand**.  **[0001437749-24-015682_intt20240331_10q.htm:3]** 

What explains the abrupt rise in Total liabilities in Q1 2024?

The large increase in Goodwill in Q1 2024 was primarily driven by **the acquisition of Alfamation S.p.A. on March 12, 2024**, which added **$11,796** to Goodwill. Additionally, there was a minor reduction of **$246** due to the impact of **foreign currency translation adjustments** in the quarter.  **[0001437749-24-015682_intt20240331_10q.htm:21]** **[0001437749-24-015682_intt20240331_10q.htm:7]** 

What factors led to the large increase in Goodwill in Q1 2024?

e6e9f68c0cf72c4cf0ee5ca086f5d05391edaca8adf9439ea064d285c88ade36

The significantly low operating income in Q4 2023 was attributed to several factors. **Lower revenue** played a major role, with a decline from **$32,405 thousand** in Q4 2022 to **$27,884 thousand** in Q4 2023—partially driven by an **$8.7 million decrease in sales to the semiconductor market**. In addition, there was a **gross margin contraction** from **46.2%** to **44.6%**, influenced by lower volumes and an unfavorable product mix, and **higher operating expenses** increased by **$391 thousand (+3.6%)**. These elements combined led to a significant drop in operating income for the quarter.  **[0001437749-24-009635_ex_645875.htm:1]** **[0001437749-24-009635_ex_645875.htm:10]** 

Why was Operating income so low in Q4 2023?

Operating income turned negative in Q2 2024 **primarily because increased operating expenses and a lower gross profit margin outweighed revenue inflows**. Specifically, the company incurred **additional operating expenses of about $2.4 million** from the Alfamation acquisition (including **$0.4 million** in amortization costs), and its gross margin contracted from **46.2% to 40.6%**. At the same time, there was a **decline in semiconductor revenue by approximately $8.7 million** due to weak market demand, collectively contributing to a roughly **90.0% drop** in operating income compared to the previous year.  **[0001437749-24-024365_ex_707064.htm:2]** **[0001437749-24-025878_intt20240630_10q.htm:39]** **[0001437749-24-025878_intt20240630_10q.htm:43]** 

Why did Operating income turn negative in Q2 2024?

The **significant lower revenue in Q4 2023** was primarily driven by a sharp **decline in semiconductor market revenue**. Specifically, revenue from the semiconductor market decreased by **$8.7 million (-44.8% YoY)** and by **$7.7 million (-41.9% sequentially)** due to a cyclical slowdown that affected both front-end and back-end sectors. This downturn outweighed the positive contributions from the industrial, auto/EV, and defense/aerospace markets, which only partially offset the loss in the semiconductor segment.  **[0001437749-24-009635_ex_645875.htm:1]** **[0001437749-24-009635_ex_645875.htm:10]** 

Why was Revenue significantly lower in Q4 2023?

The **EPS turned negative in Q2 2024** because of several compounding factors. **Sales in the semiconductor market dropped by 46% year-over-year**, which significantly reduced earnings despite record revenue largely driven by an acquisition. In addition, the **gross margin contracted from 46.2% to 40.6%** due to less favorable product mix and lower volume in higher-margin segments, while **operating expenses increased by 15.2%** as a result of incremental expenses related to the Alfamation acquisition. These factors, combined with higher interest expenses and a sharp decline in net earnings from **$2.793 million to $230,000**, led to the EPS turning negative in Q2 2024.  **[0001437749-24-024365_ex_707064.htm:2]** **[0001437749-24-024365_ex_707064.htm:8]** **[0001437749-24-024365_ex_707064.htm:1]** 

Why did EPS turn negative in Q2 2024?

e529acef523fafdab663288b74c3f2e7ecd511d8b4a5ed9fde2034b9fe85bdb7

Common stock (USD, thousands)

Additional paid-in capital (USD, thousands)

Retained earnings (USD, thousands)

Accumulated other comprehensive earnings (USD, thousands)

Treasury stock, at cost (USD, thousands)

Total stockholders' equity (USD, thousands)

Total liabilities and stockholders' equity (USD, thousands)

225eaa2c942bbe3d1eef30f7c69f4394292c177729cc294921eb67c22c94b2f3

Revenue (USD, thousands)

Cost of revenue (USD, thousands)

Gross profit (USD, thousands)

Selling expense (USD, thousands)

Engineering and product development expense (USD, thousands)

General and administrative expense (USD, thousands)

Total operating expenses (USD, thousands)

Operating income (USD, thousands)

Interest expense (USD, thousands)

Other income (USD, thousands)

Earnings before income tax expense (USD, thousands)

Income tax expense (USD, thousands)

Earnings per common share - basic (USD)

Earnings per common share - diluted (USD)

bc080e3f9a92358307ece2672bc1f25da0f2d22290604b666e3aba9727497fa8

f6835f92760b2bebf49cc8e6d5affcee25c11c3ccfd281a8aa991f968c19b12a

91289c699d65f621d08cbd28fde3c2aba7d77d9a05cf50d9793d62c9270f132a

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

cbe938cc38dfd9a8c8e75c2fd442e3b4014d8965c922ce0da50fc341f6b2bc67

United States

Foreign

Total Revenue

1a529bb550f6def6c7a10ca819e49e33c98d45d224b066770fd4328b168d8367

INTEST (INTT)

Financials